Natasa Loncarevic-Vasiljkovic

Dr. Natasa Loncarevic-Vasiljkovic

CEDOC - Centro de Estudos de Doenças Crónicas, NOVA Medical School / Faculdade de Ciências Médicas Universidade Nova de Lisboa, 1150-082 Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2012 in AGE
Verified
Journal Article
Closed access
PDF file
MPMilka Perovic
Milka Perovic
VTVesna Tesic
Vesna Tesic
ADAleksandra Mladenovic Djordjevic
Aleksandra Mladenovic Djordjevic
KSKosara Smiljanic
Kosara Smiljanic
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
SKSelma Kanazir
Selma Kanazir

15 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
VPVesna Pešić
Vesna Pešić
SPSmilja Pracer
Smilja Pracer
JPJelena Popic
Jelena Popic
KSKosara Smiljanic
Kosara Smiljanic
SKSelma Kanazir
Selma Kanazir
Traumatic brain injury (TBI) is a widespread cause of death and a major source of adult disability. Subsequent pathological events occurring in the brain after TBI, referred to as secondary injury, continue to damage surrounding tissue resulting in substantial neuronal loss. One of the hallmarks of the secondary injury process is microglial activation resulting in increased cytokine production. Notwithstanding that recent studies demonstrated that caloric restriction (CR) lasting several months prior to an acute TBI exhibits neuroprotective properties, understanding how exactly CR influences secondary injury is still unclear. The goal of the present study was to examine whether CR (50% of daily food intake for 3 months) alleviates the effects of secondary injury on neuronal loss following cortical stab injury (CSI). To this end, we examined the effects of CR on the microglial activation, tumor necrosis factor-α (TNF-α) and caspase-3 expression in the ipsilateral (injured) cortex of the adult rats during the recovery period (from 2 to 28 days) after injury. Our results demonstrate that CR prior to CSI suppresses microglial activation, induction of TNF-α and caspase-3, as well as neurodegeneration following injury. These results indicate that CR strongly attenuates the effects of secondary injury, thus suggesting that CR may increase the successful outcome following TBI.

17 May 2016 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
DMDesanka Milanovic
Desanka Milanovic
VPVesna Pešić
Vesna Pešić
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
ŽPŽeljko Pavković
Željko Pavković
JPJelena Popic
Jelena Popic
SRSabera Ruzdijic
Sabera Ruzdijic

25 August 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
DCDiogo Carregosa
Diogo Carregosa
SMSara Mota
Sara Mota
SFSofia Gravanita Ferreira
Sofia Gravanita Ferreira
BABeatriz Alves-Dias
Beatriz Alves-Dias
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
CSCláudia Nunes dos Santos
Cláudia Nunes dos Santos
The rise of neurodegenerative diseases in an aging population is an increasing problem of health, social and economic consequences. Epidemiological and intervention studies have demonstrated that diets rich in (poly)phenols can have potent health benefits on cognitive decline and neurodegenerative diseases. Meanwhile, the role of gut microbiota is ever more evident in modulating the catabolism of (poly)phenols to dozens of low molecular weight (poly)phenol metabolites that have been identified in plasma and urine. These metabolites can reach circulation in higher concentrations than parent (poly)phenols and persist for longer periods of time. However, studies addressing their potential brain effects are still lacking. In this review, we will discuss different model organisms that have been used to study how low molecular weight (poly)phenol metabolites affect neuronal related mechanisms gathering critical insight on their potential to tackle the major hallmarks of neurodegeneration.

12 August 2010 in Developmental Neuroscience
Verified
Journal Article
Closed access
PDF file
DMDesanka Milanovic
Desanka Milanovic
JPJelena Popic
Jelena Popic
VPVesna Pešić
Vesna Pešić
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
SKSelma Kanazir
Selma Kanazir
SRSabera Ruzdijic
Sabera Ruzdijic
Exposure of newborn rats to a variety of anesthetics has been shown to induce apoptotic neurodegeneration in the developing brain. We investigated the effect of the general anesthetic propofol on the brain of 7-day-old (P7) Wistar rats during the peak of synaptic growth. Caspase and calpain protease families most likely participate in neuronal cell death. Our objective was to examine regional and temporal patterns of caspase-3 and calpain activity following repeated propofol administration (20 mg/kg). P7 rats were exposed for 2, 4 or 6 h to propofol and killed 0, 4, 16 and 24 h after exposure. Relative caspase-3 and calpain activities were estimated by Western blot analysis of the proteolytic cleavage products of α-II-spectrin, protein kinase C and poly(ADP-ribose) polymerase 1. Caspase-3 activity and expression displayed a biphasic pattern of activation. Calpain activity changed in a region- and time-specific manner that was distinct from that observed for caspase-3. The time profile of calpain activity exhibited substrate specificity. Fluoro-Jade B staining revealed an immediate neurodegenerative response that was in direct relationship to the duration of anesthesia in the cortex and inversely related to the duration of anesthesia in the thalamus. At later post-treatment intervals, dead neurons were detected only in the thalamus 24 h following the 6-hour propofol exposure. Strong caspase-3 expression that was detected at 24 h was not followed by cell death after 2- and 4-hour exposures to propofol. These results revealed complex patterns of caspase-3 and calpain activities following prolonged propofol anesthesia and suggest that both are a manifestation of propofol neurotoxicity at a critical developmental stage.

22 September 2013 in Lipids
Verified
Journal Article
Closed access
PDF file
KSKosara Smiljanic
Kosara Smiljanic
Tim VanmierloTim Vanmierlo
Tim Vanmierlo
ADAleksandra Mladenovic Djordjevic
Aleksandra Mladenovic Djordjevic
MPMilka Perovic
Milka Perovic
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
SKSelma Kanazir
Selma Kanazir